Mileidys Alea-Perez

Saint-priest-la-vetre, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

ALDH1 inhibition by DIMATE maintains immune responses and promotes immunogenic remodeling in AML.

ALDH1 inhibition by DIMATE maintains immune responses and promotes immunogenic remodeling in AML.

Journal: Frontiers in immunology
Published: May 09, 2026

Resorufin-derived esters as fluorescent probes to test for the esterase activity and active-site topology of aldehyde dehydrogenase.

Resorufin-derived esters as fluorescent probes to test for the esterase activity and active-site topology of aldehyde dehydrogenase.

Journal: Chemico-biological interactions
Published: March 16, 2026

Advances in the application of lipid nanocapsules and nanostructured carriers in the treatment of lung cancer.

Advances in the application of lipid nanocapsules and nanostructured carriers in the treatment of lung cancer.

Journal: Nanomedicine (London, England)
Published: September 04, 2025

Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia.

Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia.

Journal: HemaSphere
Published: May 14, 2025

Fluorescent substrates enable specific detection and structure-function insights into human aldehyde dehydrogenase isoforms.

Fluorescent substrates enable specific detection and structure-function insights into human aldehyde dehydrogenase isoforms.

Journal: Chemico-biological interactions
Published: April 29, 2025

Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors.

Inter- and intra-tumoral ALDH1 heterogeneity in breast cancer identifies therapeutic opportunities for ALDH1A-specific inhibitors.

Journal: Cell chemical biology
Published: February 27, 2025

Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in Glioblastoma.

Targeting Retinaldehyde Dehydrogenases to Enhance Temozolomide Therapy in Glioblastoma.

Journal: International journal of molecular sciences
Published: September 13, 2024

BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy.

BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy.

Journal: Nature communications
Published: September 11, 2021

Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells.

Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells.

Journal: Gene
Published: May 19, 2020

Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.

Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.

Journal: Oncogene
Published: July 19, 2019

Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.

Genetic Profiles of Squamous Cell Carcinomas Associated with Recessive Dystrophic Epidermolysis Bullosa Unveil NOTCH and TP53 Mutations and an Increased MYC Expression.

Journal: The Journal of investigative dermatology
Published: August 07, 2017

ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.

ALDH1A3 is epigenetically regulated during melanocyte transformation and is a target for melanoma treatment.

Journal: Oncogene
Published: October 18, 2016
Showing 1-12 of 20

Last Updated: 09/26/2026